N/A
N=9
Influence of a Monopoly Game on Subtle Behaviors
Obesity · Eating Behavior
Bottom Line
View on ClinicalTrials.gov: NCT02470949 ↗Enrolled (actual)
9
Serious AEs
0.0%
Results posted
Aug 2016
Primary outcome: Primary: Calories Consumed Following the Experimental Manipulation — 647.5; 520.9 kcal
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Low Social Status (Behavioral); High Social Status (Behavioral)
- Age
- Adult · 19+ yrs
- Sex
- All
- Sponsor
- University of Colorado, Denver
- Primary completion
- Dec 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Calories Consumed Following the Experimental Manipulation |
647.5; 520.9 | — |
| PRIMARY The Macronutrient Composition of Foods Consumed |
22.4; 17.0; 89.3; 75.4; 35.4; 30.9 | — |
| PRIMARY Percent of Calories Consumed Following the Experimental Manipulation |
30.5; 27.9; 54.6; 58.0; 14.3; 12.3 | — |
Summary
This project will investigate the influence of experimentally manipulated perceived social standing on eating behavior and obesity risk.
Eligibility Criteria
Inclusion Criteria
- Ages 19-25
- Self-identified Hispanic ethnicity
- Born in the United States
- Body Mass Index (BMI) ≥18.5 and ≤30 kg/m2
- A score on the MacArthur scale of subjective social status ≥3 and ≤8
- No self-report of acute or chronic disease (heart disease, diabetes, gastrointestinal disorders in particular)
- No plans for extended travel (>1 week) within the next 2 months
- No current tobacco use
- Capable and willing to give informed consent, understand inclusion criteria, and accept the randomized assignment
Exclusion Criteria
- Never played monopoly before
- Not born in the United States
- Strict dietary restrictions (vegan, vegetarian, gluten-free, dairy-free/lactose intolerant, nut-allergies)
- Participation in any weight reduction program, weight-loss diet, or other special diet within the previous 3 months
- Weight loss or gain of ≥10 pounds in the past 6 months for any reason except post-partum weight loss
- Currently taking medication that suppresses or stimulates appetite
- Current smoker or quit smoking less than 6 months prior
- Any major disease, including:
- Active cancer or cancer requiring treatment in the past 2 years (except nonmelanoma skin cancer).
- Active or chronic infections, including self-reported HIV positivity and active tuberculosis.
- Diagnosis of cardiovascular disease
- Gastrointestinal disease, including inflammatory bowel disease that has required treatment in the past year, celiac disease, recent of significant abdominal surgery
- Active renal disease
- Lung disease such as chronic obstructive airway disease requiring use of oxygen
- Diagnosis of diabetes (type 1 or type 2)
- Uncontrolled psychiatric disease (such as schizophrenia and bipolar disorder) that, in the opinion of the investigators, would impede conduct of the trial or completion of procedures
- A score on the Brief Symptom Inventory (BSI) (Derogatis & Melisaratos, 1983) that exceeds the 90th percentile
- History of or current eating disorders, or an Eating Attitudes Test (EAT-26) score >20.
- Conditions or behaviors likely to effect the conduct of the trial: unable or unwilling to give informed consent; unable to communicate with the pertinent clinic staff; another household member is a participant or staff member in the trial; unwilling to accept social status assignment by randomization; current or anticipated participation in another intervention research project that would interfere with the intervention offered in the trial; likely to move away from participating university before visits are completed; unable to walk 0.25 mile in 10 minutes.
- Currently taking antidepressant, steroid, or thyroid medication, unless dosage has been stable for at least 6 months.
- A recent or ongoing problem with drug abuse or addiction.
- Excessive alcohol intake, either acute or chronic, defined as any one of the following: 1) average consumption of 3 or more alcohol containing beverages daily; 2) consumption of 7 or more alcoholic beverages within a 24-hr period in the past 12 months; or 3) other evidence available to clinic staff.
- Not willing to be randomized to any of the two experimental conditions.
- Pregnancy and childbearing: currently pregnant or less than 3 months post-partum; currently nursing or within 6 weeks of having completed nursing; pregnancy anticipated during study; unwilling to report possible or confirmed pregnancies promptly during the course of the trial; unwilling to take adequate contraceptive measures if potentially fertile.
- Any other conditions which, in opinion of the investigators, would adversely affect the conduct of the trial.
Data sourced from ClinicalTrials.gov (NCT02470949). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.